Comfort in Care: Transforming Opioid Treatment Environments with Elequil Aromatabs

A selection of essential oils next to open pill bottlesThe opioid crisis continues to exact a heavy toll on communities nationwide, but a new chapter in remediation has begun. With over $50 billion in settlement funds now flowing from pharmaceutical manufacturers and distributors to healthcare systems and community organizations, there is an unprecedented opportunity to strengthen opioid use disorder (OUD) treatment programs.

While much of this funding is reserved for core clinical strategies such as Medication-Assisted Treatment (MAT), withdrawal management, and recovery housing, there's a growing recognition of the importance of patient-centered care environments.

That’s where tools like Elequil Aromatabs® aromatherapy can offer supportive value, not as replacements for treatment, but as enhancements to the therapeutic environment.

Understanding What the Grants Fund

addictionrehabOpioid abatement funds are governed by criteria outlined in "Exhibit E" of the national settlement agreements. These funds must support evidence-based or evidence-informed strategies to prevent or treat OUD. Eligible uses include:

  • Expansion of FDA-approved MAT
  • Behavioral health and recovery support services
  • Harm reduction efforts like naloxone distribution
  • Peer recovery and housing programs
  • Support services in justice-involved settings
  • First responder and healthcare provider training

Importantly, these funds are not intended to support general wellness items, non-clinical amenities, or products without a clear, evidence-based role in opioid remediation. That said, tools that improve patient compliance, reduce anxiousness, or support treatment adherence may be integrated into broader, qualified interventions.

Where Elequil Aromatabs Fits: A Supportive Tool Within Treatment Settings

Elequil Aromatabs® aromatherapy is used widely in clinical environments to reduce anxiousness, soothe queasiness, and create a calming sensory experience. In the context of OUD treatment programs, Elequil may be a valuable adjunct to care when used appropriately:

  • During MAT Initiation: Calming aromatherapy may ease patient anxiousness when beginning buprenorphine or methadone.
  • In Withdrawal Management: Patients in medically supervised detox settings often experience queasiness and emotion dysregulation; Elequil Aromatabs can be part of a comfort focused protocol.
  • In Residential Treatment or Recovery Housing: Creating a more inviting, patient centered environment support engagement and retention
  • With Trauma-Informed Care: Sensory tools can play a critical role in reducing agitation and reactivity among patient with trauma histories. 

elequil-aromatabs-5-scentsWhile Elequil Aromatabs® itself is not listed as a reimbursable treatment in Exhibit E, its use within the framework of evidence-based care may strengthen patient adherence and support positive outcomes, key objectives of opioid settlement-funded programs. 

Clinical Perspective: Enhancing Adherence Through Comfort

In behavioral health and addiction medicine, patient comfort is more than a nicety, it directly affects compliance, willingness to return for follow-up, and engagement in therapy. 

Elequil Aromatabs® provides a non-pharmacologic, low-risk option to help clinicians support emotional regulation and ease physical discomfort in high-stress treatment settings. 

How to Incorporate Elequil Aromatabs Within Compliant Programs

woman_given_elequil_with_nurseAlthough Elequil Aromatabs® aromatherapy cannot be directly reimbursed through opioid abatement grants, it may be integrated into:

  • Grant-supported MAT or detox programs as a non-billable patient support tool
  • Private donor-funded components that enhance grant-funded medical care
  • Trauma-informed treatment models that utilize sensory modulation techniques

In fact, a few customers have already integrated Elequil Aromatabs® into their settings under this model.

Healthcare administrators and grant writers should ensure that Elequil Aromatabs® aromatherapy is part of a broader clinical protocol, rather than a standalone request. Including it as a line item to enhance patient retention, engagement, or comfort can align with program goals if well documented.

Supporting the Journey to Recovery

The path to opioid recovery requires a multidimensional approach - medical, behavioral, and human-centered. While Elequil Aromatabs® aromatherapy may not fulfill the core criteria for direct funding, it represents the kind of thoughtful, patient-focused care that makes other treatments more effective.

As you design or expand your opioid remediation programs, consider how enhancing the patient experience can drive better outcomes. Elequil Aromatabs® won't replace MAT or naloxone, but it may help ensure your patients return for them.

To learn how Elequil Aromatabs® are being used in behavioral health, MAT clinics, and withdrawal programs, or to request clinical samples, contact info@beekley.com.

   
Megan Sargalski

Megan Sargalski

Marketing Communications Specialist

Subscribe to BeekSpeak